COMBINATORX, INC

CAMBRIDGE, MA How do I update this listing?

Combinatorx is based out of Cambridge. Operates as a development stage biopharmaceutical company. Focuses on developing new medicines built from synergistic combinations of approved drugs. The company has a portfolio of seven product candidates targeting multiple immuno-inflammatory diseases and cancer.Whalewisdom has at least 122 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2010-12-22. The notice included securities offered of Option, Warrant or Other Right to Acquire Another Security

Create Alert

Contact Info

combinatorx, inc
245 FIRST STREET
CAMBRIDGE MA    02142

Business Phone: 617-301-7000
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2010-12-22 D BIOTECHNOLOGY Option, Warrant or Other Right to Acquire Another Security INDEFINITE 0 INDEFINITE
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
CHRISTOPHER C. GALLEN subscription required
    EXECUTIVE OFFICER
FRANK HAYDU subscription required
    DIRECTOR
HARTLEY T. RICHARDSON subscription required
    DIRECTOR
JASON F. COLE subscription required
    EXECUTIVE OFFICER
JUSTIN A. RENZ subscription required
    EXECUTIVE OFFICER
MARK H.N. CORRIGAN subscription required
    EXECUTIVE OFFICER DIRECTOR
MICHAEL G. KAUFFMAN subscription required
    DIRECTOR
SALLY W. CRAWFORD subscription required
    DIRECTOR
TODD FOLEY subscription required
    DIRECTOR
W. JAMES O'SHEA subscription required
    DIRECTOR
WILLIAM HUNTER subscription required
    DIRECTOR

Elevate your investments